Evgen Pharma

Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products.
Liverpool, GB
2 (est)

Market Position – Health, pharma, clinics, drug development

Evgen Pharma Locations

Liverpool, GB
London, GB

Evgen Pharma Metrics

Evgen Pharma Summary

Founding Date


Market capitalization

£16.5 M

Closing share price


Evgen Pharma Market Value History

Evgen Pharma News

Evgen Pharma Company Life